About

About the Doctor

Zagkla Styliani (Elina) MD, PhD(c) is a pediatrician, pediatric pulmonologist, and pediatric allergologist, with private practice in Neo Psychiko, Athens.

She is specialized in pediatric pulmonology and pediatric allergology and is a graduate of the Medical School of the University of Patras. She has many years of clinical experience in Germany in a university hospital setting, having worked at Charité – Universitätsmedizin Berlin, with a particular focus on respiratory and allergic diseases in children and adolescents.

Dr. Zagkla has extensive experience in the care of patients with cystic fibrosis and primary ciliary dyskinesia, having worked in a specialized center and actively participated in research protocols and clinical studies. In parallel, she has teaching experience as a university lecturer for medical students, with a special emphasis on pediatric pulmonology, cystic fibrosis, and pediatric allergology.

Her goal is to provide modern, evidence-based, and personalized medical care in accordance with European standards, with particular emphasis on effective communication with the child and family. She aims to offer thorough information, individualized guidance, and to build a relationship of trust between the treating physician, the patient, and their family.

Specialization

Fully certified specialization in Pediatric Pulmonology and Pediatric Allergology.

Affiliations with Hospitals and Clinics

• Metropolitan Hospital

Professional Experience

• 2026 – ongoing : Private Pediatric Practice in Pediatric Pulmonology and Pediatric Allergology, Neo Psychiko, Athens, Greece
• 2026 – ongoing : External Consultant Pediatric Pulmonologist & Pediatric Allergologist, Pediatric Department, Metropolitan Hospital, Athens, Greece
• 2022 – 2026 : Consultant in Pediatrics and Adolescent Medicine Fellowship in Pediatric Pulmonology and Pediatric Allergology Lecturer, University Pediatric Department with specialization in Pediatric Pulmonology and Immunology, Charité – Universitätsmedizin Berlin, Berlin, Germany
• 2022 – 2025 : Scientific Collaboration at a specialized Cystic Fibrosis Center, participation in research protocols and clinical studies, Cystic Fibrosis Research Center, Charité – Universitätsmedizin Berlin, Germany
• 2021 – 2022 : Residency in Pediatrics at the Private Pediatric and Pediatric Cardiology Practice of Dr. med. Martin Wiesner and Dr. med. Boris Griebenow, Berlin, Germany
• 2019 – 2021 : Resident Physician in Pediatrics and Adolescent Medicine, Department of Pediatrics, Heckeshorn, Helios Klinikum Emil von Behring, Berlin, Germany
• 2016 – 2019 : Resident Physician, Department of Pediatrics and Adolescent Medicine, Paul Gerhardt Stift, Wittenberg, Germany
• 2015 – 2016 : General Practicing Agios Markos Health Center, Corfu, Greece

Education & Qualifications

• 2025 Awarded by the Berlin Medical Chamber Qualification in Allergology (Board-certified subspecialty)
• 2024 Award of the Subspecialty Qualification in Pediatric Pulmonology, Awarded by the Berlin Medical Chamber
• 2022 Awarded by the Berlin Medical Chamber, Board Certification as Specialist in Pediatrics and Adolescent Medicine
• 2010 – 2014 University of Patras, Medical School Degree: Doctor of Medicine (MD)
• 2005 – 2009 National and Kapodistrian University of Athens, School of Nursing Degree: Bachelor of Nursing

Congresses

• 2025 Congress of the German Society of Pediatric Pulmonology, Leipzig, Germany
• 2023 European Respiratory Society (ERS) International Congress, Milan, Italy
• 2022 European Cystic Fibrosis Society (ECFS) Congress, Vienna, Austria
• 2020 Infant Hip Ultrasound according to Graf method, German Society for Ultrasound in Medicine (DEGUM)
• 2017 Interdisciplinary Basic and Advanced Abdominal Ultrasound Course (B-mode), in accordance with the guidelines of the German Society for Ultrasound in Medicine (DEGUM)
• 2014 ATLS – Advanced Trauma Life Support Course, University of Patras

Scientific Publications

• (2024 – dato) Promotion : Comparison of the effects of isotonic and hypertonic saline inhalation on MRI examinations of the paranasal sinuses in infants and children with cystic fibrosis, Clinic for Pediatrics with a focus on Pediatric Pulmonology and Immunology, Charité – Universitätsmedizin Berlin
• (2025) Prenatal Elexacaftor/Tezacaftor/Ivacaftor Treatment Prevents Meconium Ileus, but Not Exocrine Pancreatic Insufficiency and Lung Disease in Infants with Cystic Fibrosis. Aleksander PE, Thee S, Doellinger F, Zagkla S, Mall MA, Stahl M., pediatric pulmonology journal
• (2024) Elexacaftor/tezacaftor/ivacaftor improves nasal nitric oxide in patients with cystic fibrosis. Pioch CO, Ziegahn N, Allomba C, Busack LM, Schnorr AN, Tosolini A, Fuhlrott BR, Zagkla S, Othmer T, Syunyaeva Z, Graeber SY, Yoosefi M, Thee S, Steinke E, Röhmel J, Mall MA, Stahl M, Journal of cystic fibrosis

Professional Memberships

• German Society of Pediatric Pulmonology (GPP)
• German Society for Allergology and Clinical Immunology (DGAKI)
• Berlin Medical Association
• Athens Medical Association
• Piraeus Medical Association
• European Cystic Fibrosis Society (ECFS)
• European Respiratory Society (ERS)

Languages

• Greek (native)
• German (C2)
• English (C1)